Robinhood Markets Insider Sold Shares Worth $2,346,983, According to a Recent SEC Filing-March 2024-www.financetom.com

Robinhood Markets Insider Sold Shares Worth $2,346,983, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Robinhood Markets Insider Sold Shares Worth $2,346,983, According to a Recent SEC Filing

Jul 8, 2025 3:13 PM

05:37 PM EDT, 07/08/2025 (MT Newswires) -- Daniel Martin Gallagher Jr, Chief Legal Officer, on July 03, 2025, sold 25,000 shares in Robinhood Markets ( HOOD ) for $2,346,983. Following the Form 4 filing with the SEC, Gallagher has control over a total of 816,887 Class A common shares of the company, with 816,887 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1783879/000178387925000233/xslF345X05/wk-form4_1752010249.xml

Previous page： Canadian inflation rate unexpectedly eases to 2.8% in February Next page： Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Canadian inflation rate unexpectedly eases to 2.8% in February

Mar 19, 2024

OTTAWA (Reuters) -Canada's annual inflation rate in February unexpectedly cooled to 2.8%, its slowest pace since June, and core inflation measures eased to more-than two-year lows, data showed on Tuesday, raising expectations of a mid-year rate cut. Analysts polled by Reuters had forecast inflation to accelerate to 3.1% from 2.9% in January. On the month, the consumer price index rose...

Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday?

Mar 19, 2024

Enveric Biosciences ( ENVB ) shares are trading higher after the company signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for joint diseases. “We are pleased to announce that a second biotechnology company has stepped forward looking to join Enveric in moving some of the company’s promising...

Exclusive-Nordstrom's founding family in new bid to take U.S. retailer private, sources say

Mar 19, 2024

NEW YORK (Reuters) - The founding family behind Nordstrom Inc ( JWN ) is seeking to take the U.S. department store operator private, six years after a similar attempt proved unsuccessful, people familiar with the matter said on Tuesday. Nordstrom ( JWN ) has asked investment banks Morgan Stanley ( MS ) and Centerview Partners to reach out to private...

Paramount to launch ad-supported streaming plans in Canada and Australia

Mar 19, 2024

March 19 (Reuters) - Paramount Global ( PARAA ) said on Tuesday it would launch an ad-supported subscription plan across Canada and Australia. The plan will be rolled out in Canada at C$6.99 ($5.14) in April and at A$6.99 ($4.56) in Australia in June. Paramount will also expand its premium offering through Europe, starting with France this month. In France,...